Castle Biosciences Inc
CSTL
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.01B
Close$
$33.86
2.3% upside
Current Fair Value
2.3% upsideUndervalued by 2.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.01 Billion |
|---|---|
| Enterprise Value | $985.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 0.95 |
| Outstanding Shares | 30,399,000 |
Return
| Return on Equity | -4.13% |
|---|---|
| Return on Assets | -3.46% |
| Return on Invested Capital | -4.74% |
Valuation & Multiples
| P/E Ratio | -50.16 |
|---|---|
| PEG | 34.46 |
| Price to Sales | 3.01 |
| Price to Book Ratio | 2.21 |
| Enterprise Value to Revenue | 2.76 |
| Enterprise Value to EBIT | -41.21 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$-0.44
Average shareholder expectationRevenue Estimate
$86.37 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$92.41 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.51%▼ 91.12% |
|---|---|
| Total Invested | $16.20M▼ 97.55% |
| Investors Holding | 24▼ 156.00% |
ESG Score
No data